ACHL

ACHL


A Deep Dive into HIV Infection as a Contributor to Cardiovascular Disease

This text-based eNewsletter is the second in a four-part series. It reviews the contributions of chronic inflammation, immune activation, and other factors to increased CVD risk in HIV-infected individuals. Short audio commentary provided by Dr. Edgar Turner Overton compliments text and provides practical information. Use the "Ask The Expert" button (available when logged in) to submit a ques...
ACHL

ACIP Recommendations for Adult Pneumococcal Immunization

The incidence of pneumococcal disease in the U.S. is highest in adults over the age of 65 years. These patients also have more serious disease and medical costs due to hospitalization than younger adults. However, rates of pneumococcal vaccinations in older adults are suboptimal and fall below established goals despite available recommendations and awareness campaigns. In light of their patient-...
ACHL

Advances & Controversies in Malignant Hematology & Oncology: Hematology Expert Insights

Advances & Controversies in Malignant Hematology & Oncology is a one-day comprehensive meeting that presents the latest data and cutting-edge updates in the rapidly evolving fields of malignant hematology and oncology. Advances & Controversies is unique in that it addresses questions and controversies emerging from the American Society of Hematology (ASH), American Society of Clinical Oncology (...
ACHL

Advances & Controversies in Malignant Hematology & Oncology: Hematology Expert Insights 2

Advances & Controversies in Malignant Hematology & Oncology is a one-day comprehensive meeting that presents the latest data and cutting-edge updates in the rapidly evolving fields of malignant hematology and oncology. Advances & Controversies is unique in that it addresses questions and controversies emerging from the American Society of Hematology (ASH), American Society of Clinical Oncology (...
ACHL

Advances & Controversies in Malignant Hematology & Oncology: Solid Tumor Expert Insights

Advances & Controversies in Malignant Hematology & Oncology is a one-day comprehensive meeting that presents the latest data and cutting-edge updates in the rapidly evolving fields of malignant hematology and oncology. Advances & Controversies is unique in that it addresses questions and controversies emerging from the American Society of Hematology (ASH), American Society of Clinical Oncology (...
ACHL

Antiretroviral Therapy and Cardiovascular Risks in HIV

The use of ART reduces CVD risks in HIV-infected individuals. Yet, many patients develop lipid abnormalities that require a change in therapy or addition of lipid-lowering therapy. Clinicians must be familiar with available data to select therapies and avoid complications for their patients. This text-based eNewsletter is the third in a four-part series. It reviews the benefits of antiretrovi...
ACHL

Case Managers and Their Role in Improving Patient Outcomes in Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a rare, progressive lung disease that greatly impacts patients’ quality of life and diminishes life expectancy. Newer therapies slow lung function decline. These therapies are used in combination with oxygen supplementation, pulmonary rehabilitation, symptomatic treatment, and supportive care. Case managers and respiratory therapists need education on the...
ACHL

Comprehensive Strategies to Improve Clinical Outcomes in Heart Failure

This enduring webcast features an expert panel of three faculty members who will participate in an interactive discussion that will integrate problem-based learning with evidence-based medicine to help incorporate newly issued guideline updates into clinical practice. Panel sessions and audience participation will help to highlight how medical therapies may be combined with devices, and how post...
ACHL

Exploring Advances in Primary Immunodeficiencies: Expert Interview

This activity aims to increase the knowledge and competence of immunologists, allergists, primary care providers and other clinicians involved in the management of patients with primary immunodeficiencies (PI). Differences in how clinicians manage patients with primary immunodeficiencies underscore areas where improved educational and training initiatives may benefit patient care. In this ac...
ACHL

From Provider To Patient: Opportunities and Dialogue for Appropriate Pain Management

This activity educates physicians, pharmacists, and other allied health personnel on the latest CDC guidelines surrounding prescription opioids as well as the latest epidemiological data surrounding addiction management and treatment. Multiple expert physicians trained in pain management as well as addiction management will discuss current best practices in both disciplines, while academic pharm...
ACHL

From Provider To Patient: Opportunities and Dialogue for Appropriate Pain Management

This activity educates physicians, pharmacists, and other allied health personnel on the latest CDC guidelines surrounding prescription opioids as well as the latest epidemiological data surrounding addiction management and treatment. Multiple expert physicians trained in pain management as well as addiction management will discuss current best practices in both disciplines, while academic pharm...
ACHL

From Psoriasis to Psoriatic Arthritis: Incorporating Advances to Individualize Treatment

Drs. Kenneth B. Gordon and Alexis Ogdie-Beatty facilitate a critical review and discuss up-to-date data impacting psoriasis and psoriatic arthritis (PsA) at the point of care. This activity is intended for dermatologists, rheumatologists, primary care physicians, nurse practitioners, pharmacists, and other affiliated providers involved in the diagnosis and treatment of patients with psoriasis...
ACHL/Purdue University College of Pharmacy

Interstitial Lung Disease: A Year in Review

This text-based activity will focus on the benefits of early diagnosis and appropriate treatment modalities for managing patients with interstitial lung disease (ILD). It will educate clinicians on recognizing varied disease presentations, mechanisms associated with the disease, common complications and improved drug delivery methodologies. It includes images, charts and audio clips featuring fa...
ACHL

Navigating Changes in LDL Management: Focus on PCSK9 Inhibitors Meeting Coverage from the CRT Conference 2017

This live symposium coverage at the CRT Conference 2017 in Washington D.C. features expert faculty who discuss current changes and challenges in LDL management in an evolving therapeutic environment. New therapeutic agents, including PCSK9 inhibitors and their role in the existing statin-based drug armamentarium, are evaluated from a risk-benefit profile as an option for treating populations who...
ACHL

Nutrition for the Preterm Infant: Impact on Growth, Development, and Intestinal Health

Surveillance by the Centers for Disease Control and Prevention has identified pervasive nutritional problems in infants and young children in the United States.(Reinold 2009; Polhamus 2007) Although breastfeeding is the gold standard in infant nutrition, there are a number of factors that may impact infant breastfeeding (ability, frequency and amount of intake): infant age and development (prete...
ACHL

Office-Based Infusions Toolkit: A Setup Guide for Your Practice

Do you want to improve immunology care outcomes, increase medication compliance rates, grow your practice, and improve your relationship with patients? If so, then an in-house infusion clinic might be right for you and your patients. View this detailed, yet simple practice-setup guide for: - Business and financial planning templates - Infusion pricing and reimbursement information...
ACHL

Participatory Medicine in IPF: Bridging Communication Gaps Between Clinicians, Patients and Caregivers

This educational activity consists of two, 30-minute digital classroom activities designed to engage clinicians that treat patients with idiopathic pulmonary fibrosis (IPF). A patient education activity has been developed as well to help bridge the communication gap between clinicians and patients, while providing an educational resource developed specific for the patient and caregiver. Upo...
ACHL

Primary Prevention Strategies for HIV-related Cardiovascular Disease

The use of ART prolongs survival and reduces CVD risks in HIV-infected individuals. However, the HIV-infected population also has high rates of traditional CVD, such as dyslipidemia. Clinicians must be familiar with available data to manage these risks and formulate preventive approaches. This educational activity is designed for cardiologists, infectious disease specialists, primary care phy...
ACHL

Recurrent C. difficile Infection: Expert Perspectives on Impacting Clinical Outcomes and Economics

This CME activity addresses the management of recurrent Clostridium difficile infection (CDI), including identification of at-risk patients, evidence-based treatment, and its economic impact. In this text-based interview, two faculty will discuss their approaches to the prevention and management of recurrent CDI. This is the second in a series of five educational activities on CDI to be released...
ACHL

Strategies for Preventing HIV-related Cardiovascular Disease

This text-based interview is the first of a four-part series. Dr. Chris Longenecker and Dr. Turner Overton address CVD risks in HIV-infected individuals, such as contributing factors for CVD (inflammation and immune activation), the impact of antiretroviral drug treatment (ART), risk factor modification, and ongoing clinical trials. HIV-infected individuals have an increased risk of CVD. Res...
ACHL

Strategies to Control nOH: Clinician and Patient Perspectives

Online, text-based interview activity which will include clinician and patient perspectives. The goal of this activity is to update clinicians on new and emerging science in the field of neurogenic orthostatic hypotension (nOH) to provide practicing clinicians with education on optimal use of new agents.
ACHL

The Emerging Science of Prophylactic Therapies for Migraine

Patients with frequent migraines and/or who experience functional disability need preventative migraine treatment. However, studies have shown that of the 38% of patients who stand to benefit from prophylactic therapy, only 3-13% of them actually receive it. Calcitonin gene-related peptide (CGRP) monoclonal antibodies are under clinical investigation and constitute a new prophylactic migraine th...
ACHL

Updates in the Treatment and Prevention of C. difficile: Hospital Perspectives

This CME activity addresses hospital perspectives on C. difficile infection such as surveillance, preventive strategies and tailoring therapy to disease severity and patient factors. In this video-based interview, two faculty will discuss their approaches to the prevention and management of CDI and recurrent CDI in the hospital setting. This is the third in a series of five educational activitie...
ACHL

Updates in the Treatment of C. difficile Infection: Faculty Insights

This CME activity addresses recent developments in the treatment and prevention of Clostridium difficile infection (CDI) and its recurrence. In these video-based interviews, two faculty discuss the clinical implications of recently released data on the management of CDI. This is the first in a series of five educational activities on CDI to be released in 2017. Clostridium difficile infectio...
ACHL

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.